-
clinical applications. Candidates should hold a PhD in molecular biology, cell biology, biochemistry, genetics, bioengineering, or a related discipline by the start date. Evidence of scientific productivity
-
strategies in CNS tumors by linking cellular states to functional vulnerabilities arising from their intrinsic molecular and phenotypic heterogeneity. The project will integrate single-cell and bulk multi
-
PhD in biology, biochemistry or equivalent Proven experience in research of MLLr acute leukemia Broad expertise in basic cell-molecular and biochemical techniques (Western blotting, immunoprecipitations
-
perform cellular and molecular experiments (e.g. flow cytometry, ELISA/Luminex, qPCR, Western blot, cell culture, primary immune cell work), and analyse/interrogate datasets together with the team. Support
-
. Klinik Kinderheilkunde III (Onkologie, Hämatologie und Immunologie, Pneumologie) Andreas Kulozik, MD, PhD Im Neuenheimer Feld 430 69120 Heidelberg Note: The UKHD is subject to the provisions